Natural Immune Systems Inc   Report issue

For profit Phase 2 Phase 4
Founded: Klamath Falls OR United States (1999)

Organization Overview

First Clinical Trial
2012
NCT02886507
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Natural Immune Systems Inc | Natural Immunogenics Corp.

Active Ingredients

Drugs in Phase 4 Trials (1)

nattokinase (1 trial)

Drugs in Phase 2 Trials (1)

jobelyn (1 trial)

Drugs in Other Trials (9)

aminosol (1 trial)

black tea extract (1 trial)

curcumin (1 trial)

ergothioneine (1 trial)

nigella sativa (1 trial)

protein hydrolysates (1 trial)

silver hydrosol (1 trial)

turmeric (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 11